NO20002314L - Nye 2,3-metano-aminosyreforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem - Google Patents
Nye 2,3-metano-aminosyreforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende demInfo
- Publication number
- NO20002314L NO20002314L NO20002314A NO20002314A NO20002314L NO 20002314 L NO20002314 L NO 20002314L NO 20002314 A NO20002314 A NO 20002314A NO 20002314 A NO20002314 A NO 20002314A NO 20002314 L NO20002314 L NO 20002314L
- Authority
- NO
- Norway
- Prior art keywords
- optionally substituted
- alkyl
- new
- preparation
- aryl
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 2
- -1 amino, amidino Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
- 125000005140 aralkylsulfonyl group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 abstract 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9905601A FR2793248B1 (fr) | 1999-05-03 | 1999-05-03 | Nouveaux derives de 2,3-methano-aminoacides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20002314D0 NO20002314D0 (no) | 2000-05-02 |
| NO20002314L true NO20002314L (no) | 2000-11-06 |
Family
ID=9545154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20002314A NO20002314L (no) | 1999-05-03 | 2000-05-02 | Nye 2,3-metano-aminosyreforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6288077B1 (pl) |
| EP (1) | EP1050534B1 (pl) |
| JP (1) | JP3200053B2 (pl) |
| KR (1) | KR100439599B1 (pl) |
| CN (1) | CN1130347C (pl) |
| AT (1) | ATE210131T1 (pl) |
| AU (1) | AU763670B2 (pl) |
| BR (1) | BR0002075A (pl) |
| CA (1) | CA2308780C (pl) |
| DE (1) | DE60000036T2 (pl) |
| DK (1) | DK1050534T3 (pl) |
| EA (1) | EA002645B1 (pl) |
| ES (1) | ES2169716T3 (pl) |
| FR (1) | FR2793248B1 (pl) |
| HU (1) | HUP0001712A3 (pl) |
| MX (1) | MXPA00004241A (pl) |
| NO (1) | NO20002314L (pl) |
| NZ (1) | NZ504298A (pl) |
| PL (1) | PL198571B1 (pl) |
| PT (1) | PT1050534E (pl) |
| SI (1) | SI1050534T1 (pl) |
| ZA (1) | ZA200002152B (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6774110B2 (en) * | 2001-03-19 | 2004-08-10 | Lg Life Sciences Ltd. | Orally available peptidic thrombin inhibitors |
| JP2003072059A (ja) * | 2001-06-21 | 2003-03-12 | Ricoh Co Ltd | インクジェット記録装置及び複写機 |
| TW200911787A (en) * | 2007-07-03 | 2009-03-16 | Astrazeneca Ab | New aza-bicyclohexane compounds useful as inhibitors of thrombin |
| AR072278A1 (es) * | 2008-06-23 | 2010-08-18 | Astrazeneca Ab | Compuestos inhibidores de trombina |
| CN116813691B (zh) * | 2018-10-29 | 2024-04-12 | 丽珠医药集团股份有限公司 | 新的二肽类化合物及其用途 |
| US20240208923A1 (en) | 2021-03-10 | 2024-06-27 | Jnana Therapeutics Inc. | Small molecule inhibitors of mammalian slc6a19 function |
| WO2024015574A1 (en) * | 2022-07-14 | 2024-01-18 | Jnana Therapeutics Inc. | Small molecule inhibitors of mammalian slc6a19 function |
| CN120225188A (zh) * | 2022-11-30 | 2025-06-27 | 杰那医疗公司 | Slc6a19功能哌啶抑制剂的晶体形式 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4954158A (en) * | 1983-08-16 | 1990-09-04 | University Of Georgia Research Foundation, Inc. | 2,3-methanoproline |
| FR2701951B1 (fr) * | 1993-02-24 | 1995-06-09 | Adir | Nouveaux derives peptidiques de l'acide boronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| ZA951617B (en) * | 1994-03-04 | 1997-02-27 | Lilly Co Eli | Antithrombotic agents. |
| US5688826A (en) * | 1995-11-16 | 1997-11-18 | Eli Lilly And Company | Excitatory amino acid derivatives |
| US6110930A (en) * | 1997-04-10 | 2000-08-29 | Ono Pharmaceutical Co., Ltd. | Condensed piperidine compound |
-
1999
- 1999-05-03 FR FR9905601A patent/FR2793248B1/fr not_active Expired - Fee Related
-
2000
- 2000-04-27 EA EA200000374A patent/EA002645B1/ru not_active IP Right Cessation
- 2000-04-28 PL PL339967A patent/PL198571B1/pl unknown
- 2000-04-30 CN CN00119227A patent/CN1130347C/zh not_active Expired - Fee Related
- 2000-05-02 EP EP00401197A patent/EP1050534B1/fr not_active Expired - Lifetime
- 2000-05-02 DE DE60000036T patent/DE60000036T2/de not_active Expired - Fee Related
- 2000-05-02 DK DK00401197T patent/DK1050534T3/da active
- 2000-05-02 SI SI200030004T patent/SI1050534T1/xx unknown
- 2000-05-02 US US09/561,618 patent/US6288077B1/en not_active Expired - Fee Related
- 2000-05-02 NO NO20002314A patent/NO20002314L/no not_active Application Discontinuation
- 2000-05-02 HU HU0001712A patent/HUP0001712A3/hu unknown
- 2000-05-02 NZ NZ504298A patent/NZ504298A/xx unknown
- 2000-05-02 ES ES00401197T patent/ES2169716T3/es not_active Expired - Lifetime
- 2000-05-02 MX MXPA00004241A patent/MXPA00004241A/es active IP Right Grant
- 2000-05-02 PT PT00401197T patent/PT1050534E/pt unknown
- 2000-05-02 AT AT00401197T patent/ATE210131T1/de not_active IP Right Cessation
- 2000-05-03 AU AU31325/00A patent/AU763670B2/en not_active Ceased
- 2000-05-03 CA CA002308780A patent/CA2308780C/fr not_active Expired - Fee Related
- 2000-05-03 ZA ZA200002152A patent/ZA200002152B/xx unknown
- 2000-05-03 KR KR10-2000-0023669A patent/KR100439599B1/ko not_active Expired - Fee Related
- 2000-05-03 BR BR0002075-3A patent/BR0002075A/pt not_active Application Discontinuation
- 2000-05-08 JP JP2000134144A patent/JP3200053B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0211844B8 (pt) | composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica | |
| NO20052683L (no) | Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20085077L (no) | Nye forbindelser | |
| DE69820248D1 (de) | Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben | |
| NO990227D0 (no) | Heterocykliske forbindelser som farmas°ytika | |
| BRPI0213243B8 (pt) | composto heterocíclico aromático contendo um anel oxazol, tiazol ou imidazol, ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica | |
| EP1396493A4 (en) | HETEROCYCLIC COMPOUNDS | |
| CA2336412A1 (en) | Medicament for treatment of diabetes | |
| NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
| PT1216245E (pt) | Derivados sulfonil-hidrazida farmaceuticamente activos | |
| NO20002314D0 (no) | Nye 2,3-metano-aminosyreforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem | |
| NO20025035D0 (no) | Oksadiazolderivater som har anticancer-effekter | |
| NO20022552D0 (no) | Nye benzotiadiazinderivater, deres fremstilling og farmasöytiske sammensetninger inneholdende det samme | |
| NO20026004D0 (no) | Nye podofyllotoksinkarbamat- og tiokarbamatforbindelser, fremgangsmåte vedderes fremstilling og farmasöytiske sammensetninger inneholdendedem | |
| ES2080175T3 (es) | Estabilizador para una preparacion que contiene 4-etil-2-hidroxiimino-5-nitro-3-hexenamida y metodo de estabilizacion correspondiente. | |
| ATE323484T1 (de) | Neue pharmazeutische verbindungen mit alpha2receptor aktivität | |
| EA200400667A3 (ru) | Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат | |
| IL169577A0 (en) | Oligosaccharide derivatives and pharmaceutical compostions containing the same | |
| DE60238847D1 (de) | Pyrimidinderivate enthaltendes medikament | |
| MXPA04005839A (es) | Nuevos compuestos de benzotiazina y benzotiadiazina un proceso para su preparacion y las composiciones farmaceuticas que los contienen. | |
| DK0611755T3 (da) | Hidtil ukendte (cyklohexyl)alkenforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| IL44230A (en) | 3-substituted-1-(4-(2-(4-methyl-5-thiazolecarboxamido)-ethyl) benzenesulfonyl)urea derivatives and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |